Interventional Radiology

General Information

P.O. Box 208042, South Pavilion 2-213
New Haven, CT 06520-8042


Yale Interventional Radiology consists of a division of physicians specializing in the use of imaging modalities to guide the performance of minimally invasive diagnostic and therapeutic procedures in numerous parts of the body. Additionally, we are closely allied with Yale Vascular Surgery in a Yale Vascular Center, especially in the evaluation and treatment of arterial and venous blockages and aneurysms, including newer methods for angioplasty, the removal of material causing arterial blockage, and stent-grafts for aneurysms.

Clinical Interests

Other clinical interests include embolization for uterine fibroids, vascular anomalies, and pelvic congestion syndrome and varicoceles; minimally invasive treatment of cancer using embolization (including chemoembolization) and local treatments such as radiofrequency ablation; the management of varicose veins; interventions in bile ducts and the urinary track; and the placement of a variety of venous access devices.

Through the Yale Vascular Malformation Center, we are a world leader in the evaluation and treatment of patients with hereditary hemorrhagic telangiectasia (HHT, or Osler-Weber-Rendu syndrome).

Yale Interventional Radiologists see patients at our office in the Yale Physicians’ Building on Howard Avenue and perform procedures at Yale-New Haven Hospital and at the Veterans Administration Medical Center. In addition, we are active in training residents and fellows and conduct research.

Research Direction

  • Outcome of embolotherapy for pulmonary arteriovenous malformations
  • Transjugular intrahepatic portosystemic shunts
  • Locoregional therapy for hepatocellular carcinoma
  • Outcome after uterine fibroid embolization
  • Carotid artery stenosis
  • Thrombolytic spects and applications
  • CT angiography of peripheral vascular disease
  • Dynamic vascular imaging
  • Clinical applications of phase contrast imaging
  • Hemodialysis access catheters
  • Endovascular surgery
  • Stent technology
  • Vascular imaging: improving vascular outcomes
  • Fenestrated endografts; branched endografts
  • Embolotherapy technics
  • Vascular malformations
  • Male infertility
  • Pelvic congestion syndrome and fibroid disease
  • Hereditary Hemorrhagic Telangiectasia

Recent Publications

The Young's procedure for severe epistaxis from hereditary hemorrhagic telangiectasia. Richer SL, Geisthoff UW, Livada N, Ward PD, Johnson L, Mainka A, Henderson KJ, Maune S, White RI Jr, Ross DA. Am J Rhinol Allergy. 2012 Sep;26(5):401-4. doi: 10.2500/ajra.2012.26.3809. PMID: 23168156

Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: gene-phenotype correlations. Nishida T, Faughnan ME, Krings T, Chakinala M, Gossage JR, Young WL, Kim H, Pourmohamad T, Henderson KJ, Schrum SD, James M, Quinnine N, Bharatha A, Terbrugge KG, White RI Jr. Am J Med Genet A. 2012 Nov;158A(11):2829-34. doi: 10.1002/ajmg.a.35622. Epub 2012 Sep 18. 22991266

Distal Cross-sectional Occlusion Is the “Key” to Treating Pulmonary Arteriovenous Malformations. Jeffrey S. Pollak, MD, Robert I. WhiteJr, MD. Journal of Vascular and Interventional Radiology, Vol 23, Issue 12, December 2012, Pages 1578–1580.    S1051044312010366

Reproducibility of Oxygen Saturation Monitoring During Six-Minute Walk Test and Exercise Stress Test in Patients with Pulmonary Arteriovenous Malformations Associated With Hereditary Hemorrhagic Telangiectasia. Li W, Niu B, Henderson K, Northrup V, Pollak JS, Trow T, Fahey J, White RI Jr. Pediatr Cardiol. 2011 Feb 19. [Epub ahead of print] PubMed PMID: 21336824.

International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, Spears J, Brown DH, Buscarini E, Chesnutt MS, Cottin V, Ganguly A, Gossage JR, Guttmacher AE, Hyland RH, Kennedy SJ, Korzenik J, Mager JJ, Ozanne AP, Piccirillo JF, Picus D, Plauchu H, Porteous ME, Pyeritz RE, Ross DA, Sabba C, Swanson K, Terry P, Wallace MC, Westermann CJ, White RI, Young LH, Zarrabeitia R; HHT Guidelines Working Group. J Med Genet. 2011 Feb;48(2):73-87. Epub 2009 Jun 23. PubMed PMID: 19553198.

Hemothorax due to rupture of pulmonary arteriovenous malformation: an interventional emergency. Berg AM, Amirbekian S, Mojibian H, Trow TK, Smith SJ, White RI Jr. Chest. 2010 Mar;137(3):705-7. PubMed PMID: 20202952.

Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP-HHT syndrome. Gallione C, Aylsworth AS, Beis J, Berk T, Bernhardt B, Clark RD, Clericuzio C, Danesino C, Drautz J, Fahl J, Fan Z, Faughnan ME, Ganguly A, Garvie J, Henderson K, Kini U, Leedom T, Ludman M, Lux A, Maisenbacher M, Mazzucco S, Olivieri C, Ploos van Amstel JK, Prigoda-Lee N, Pyeritz RE, Reardon W, Vandezande K, Waldman JD, White RI Jr, Williams CA, Marchuk DA. Am J Med Genet A. 2010 Feb;152A(2):333-9. PubMed PMID: 20101697.

2009 Treatment guidelines for hereditary hemorrhagic telangiectasia. Trerotola SO, Pyeritz RE, White RI Jr, Picus D, Miller FJ; HHT Foundation; HHT Centers. J Vasc Interv Radiol. 2010 Feb;21(2):179. Epub 2009 Dec 21. PubMed PMID: 20022766.